CLINICAL USE
Antiviral: Herpes zoster and simplex Prevention of cytomegalovirus (CMV) disease after renal transplantation
DOSE IN NORMAL RENAL FUNCTION
Herpes simplex: 500 mg twice daily for 5–10 days Herpes zoster: 1 g 3 times a day for 7 days Herpes simplex suppression: 500 mg daily in 1–2 divided doses (500 mg twice daily in the immunocompromised) Prevention of CMV disease: 1 g 3 times a day for 90 days
PHARMACOKINETICS
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
30–50 Dose as in normal renal function 15–30 Herpes simplex: Dose as in normal renal function Herpes zoster: 1 g every 12 hours CMV prophylaxis: 1 g every 12 hours <15 Herpes simplex: 500 mg daily Herpes zoster: 1 g every 24 hours CMV prophylaxis: 1 g every 24 hours Herpes simplex suppression: Immunocompetent – 250 mg daily Immunocompromised – 500 mg daily
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
Almost completely (80%) converted to aciclovir – see aciclovir monograph for further information